JP2021502382A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021502382A5 JP2021502382A5 JP2020526001A JP2020526001A JP2021502382A5 JP 2021502382 A5 JP2021502382 A5 JP 2021502382A5 JP 2020526001 A JP2020526001 A JP 2020526001A JP 2020526001 A JP2020526001 A JP 2020526001A JP 2021502382 A5 JP2021502382 A5 JP 2021502382A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- oral pharmaceutical
- rifamycin
- solid dosage
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023101775A JP7651620B2 (ja) | 2017-11-10 | 2023-06-21 | 経口リファマイシンｓｖ組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762584226P | 2017-11-10 | 2017-11-10 | |
| US62/584,226 | 2017-11-10 | ||
| PCT/IB2018/058748 WO2019092614A1 (en) | 2017-11-10 | 2018-11-07 | Oral rifamycin sv compositions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023101775A Division JP7651620B2 (ja) | 2017-11-10 | 2023-06-21 | 経口リファマイシンｓｖ組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021502382A JP2021502382A (ja) | 2021-01-28 |
| JP2021502382A5 true JP2021502382A5 (cg-RX-API-DMAC7.html) | 2021-11-18 |
Family
ID=64426987
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020526001A Pending JP2021502382A (ja) | 2017-11-10 | 2018-11-07 | 経口リファマイシンｓｖ組成物 |
| JP2023101775A Active JP7651620B2 (ja) | 2017-11-10 | 2023-06-21 | 経口リファマイシンｓｖ組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023101775A Active JP7651620B2 (ja) | 2017-11-10 | 2023-06-21 | 経口リファマイシンｓｖ組成物 |
Country Status (17)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022102198A (ja) * | 2020-12-25 | 2022-07-07 | ライオン株式会社 | 内服固形剤 |
| US20220280478A1 (en) * | 2021-03-05 | 2022-09-08 | Bausch Health Ireland, Limited | Methods of using rifamycin sv for the treatment of sickle cell disease |
| EP4412588A1 (en) * | 2021-10-05 | 2024-08-14 | Cosmo Technologies Ltd | An in-situ gelling enema of rifamycin for treating pouchitis and distal ulcerative colitis |
| WO2025064599A1 (en) * | 2023-09-19 | 2025-03-27 | The United States Government As Represented By The Department Of Veterans Affairs | Rifamycin composition for treating sarcopenia |
| WO2025157240A1 (zh) * | 2024-01-26 | 2025-07-31 | 丹诺医药（苏州）股份有限公司 | 化合物用于制备治疗细菌代谢相关疾病的药物的用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6861053B1 (en) * | 1999-08-11 | 2005-03-01 | Cedars-Sinai Medical Center | Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
| CA2377301C (en) | 1999-06-14 | 2009-05-12 | Cosmo S.P.A. | Controlled release and taste masking oral pharmaceutical compositions |
| WO2005030173A1 (en) | 2003-09-25 | 2005-04-07 | Ranbaxy Laboratories Limited | Colon-specific drug delivery using interpolymer complexations |
| ITMI20041295A1 (it) | 2004-06-25 | 2004-09-25 | Cosmo Spa | Composizioni farmaceutiche antimicrobiche orali |
| KR20080081351A (ko) | 2006-01-04 | 2008-09-09 | 도꾜 메디칼 앤드 덴탈 유니버시티 | 간장 질환 치료제 및 간기능 개선제 |
| BRPI0908026B8 (pt) | 2008-02-26 | 2021-05-25 | Salix Pharmaceuticals Ltd | uso de rifaximina no tratamento de doenças do intestino |
| HRP20200284T1 (hr) | 2008-10-02 | 2020-07-10 | Salix Pharmaceuticals, Ltd. | Postupci liječenja hepatičke encefalopatije |
| US7928115B2 (en) * | 2008-10-02 | 2011-04-19 | Salix Pharmaceuticals, Ltd. | Methods of treating travelers diarrhea and hepatic encephalopathy |
| US8741048B2 (en) | 2011-08-30 | 2014-06-03 | Brother Kogyo Kabushiki Kaisha | Water-based ink for ink-jet recording and ink cartridge |
| IN2014DN06662A (cg-RX-API-DMAC7.html) | 2012-02-13 | 2015-05-22 | Cosmo Technologies Ltd | |
| WO2016003536A1 (en) | 2014-06-30 | 2016-01-07 | Salix Pharmaceuticals, Inc. | Methods for retreating irritable bowel syndrome (ibs) |
| WO2017053885A1 (en) * | 2015-09-25 | 2017-03-30 | Glaukos Corporation | Punctal implants with controlled drug delivery features and methods of using same |
-
2018
- 2018-11-07 EP EP24193102.1A patent/EP4438039A3/en active Pending
- 2018-11-07 EP EP24192746.6A patent/EP4431094A3/en active Pending
- 2018-11-07 JP JP2020526001A patent/JP2021502382A/ja active Pending
- 2018-11-07 PL PL18807426.4T patent/PL3706724T3/pl unknown
- 2018-11-07 CA CA3078900A patent/CA3078900A1/en active Pending
- 2018-11-07 AU AU2018364617A patent/AU2018364617B2/en active Active
- 2018-11-07 WO PCT/IB2018/058748 patent/WO2019092614A1/en not_active Ceased
- 2018-11-07 DK DK18807426.4T patent/DK3706724T3/da active
- 2018-11-07 US US16/762,760 patent/US11564883B2/en active Active
- 2018-11-07 CN CN201880072798.7A patent/CN111328279B/zh active Active
- 2018-11-07 ES ES18807426T patent/ES2989706T3/es active Active
- 2018-11-07 BR BR112020009171-5A patent/BR112020009171A2/pt unknown
- 2018-11-07 EP EP18807426.4A patent/EP3706724B1/en active Active
- 2018-11-07 IL IL274414A patent/IL274414B2/en unknown
- 2018-11-07 KR KR1020207014333A patent/KR102747348B1/ko active Active
- 2018-11-07 MX MX2020004706A patent/MX2020004706A/es unknown
- 2018-11-07 FI FIEP18807426.4T patent/FI3706724T3/fi active
- 2018-11-07 AR ARP180103244A patent/AR114140A1/es unknown
-
2020
- 2020-05-13 ZA ZA2020/02726A patent/ZA202002726B/en unknown
-
2022
- 2022-12-27 US US18/146,510 patent/US12036316B2/en active Active
-
2023
- 2023-06-21 JP JP2023101775A patent/JP7651620B2/ja active Active
-
2024
- 2024-05-30 US US18/678,539 patent/US20240398699A1/en active Pending